Publisher
Springer Berlin Heidelberg
Reference14 articles.
1. Bricker NS (1972) On the pathogenesis of the uremic state: an exposition of the „trade off“ hypothesis. N Engl J Med 286:1093–1099
2. Cavatorta F, Delfino G, Solari P, Vagge R, Queirolo C (1989) L’uso del diclorometilendifosfonato del trattamento dell’osteodistrofia uremica: dati preliminari. G Ital Nefrol 6:135
3. Hamdy NAT, Gray RES, McCloskey E, Galloway J, Rattenbury JM, Brown CB, Kanis JA (1987) Clodronate in the medical management of hyperparathyroidism. Bone [Suppl 1] 8:569–577
4. Hamdy NAT, McCloskey EV, Brown CB, Kanis JA (1990) Effects of clodronate in severe hyperparathyroid bone disease in chronic renal failure. Nephron 56:6–12
5. Hene RJ, Visser WJ, Duursma SA, Raymakers JA, De Bos Kuil RJ, Doriiout Mees EJ (1990) No effect of APD (amino hydroxypropylidene bisphosphonate) on hypercalcemia in patients with renal osteodystrophy. Bone 11:15–20